The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS G12D -driven non-small cell lung cancer.

MLA

McDaid, W. J., et al. “The PI3K-AKT-MTOR Axis Persists as a Therapeutic Dependency in KRAS G12D -Driven Non-Small Cell Lung Cancer.” Molecular Cancer, vol. 23, no. 1, Nov. 2024, p. 253. EBSCOhost, https://doi.org/10.1186/s12943-024-02157-x.

APA

McDaid, W. J., Wilson, L., Adderley, H., Martinez-Lopez, A., Baker, M. J., Searle, J., Ginn, L., Budden, T., Aldea, M., Marinello, A., Aredo, J. V., Viros, A., Besse, B., Wakelee, H. A., Blackhall, F., Castillo-Lluva, S., Lindsay, C. R., & Malliri, A. (2024). The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS G12D -driven non-small cell lung cancer. Molecular Cancer, 23(1), 253. https://doi.org/10.1186/s12943-024-02157-x

Chicago

McDaid, W J, L Wilson, H Adderley, A Martinez-Lopez, M J Baker, J Searle, L Ginn, et al. 2024. “The PI3K-AKT-MTOR Axis Persists as a Therapeutic Dependency in KRAS G12D -Driven Non-Small Cell Lung Cancer.” Molecular Cancer 23 (1): 253. doi:10.1186/s12943-024-02157-x.